Funding Round attributes
ApiJect Systems, Corp., a company specializing in advanced drug delivery systems, announced a significant financial boost with a $35 million equipment financing commitment from Trinity Capital. This financing arrangement is a strategic step for ApiJect as it seeks to expand its production capabilities and enhance its innovative injectable delivery systems.
ApiJect is known for its role in revolutionizing the pharmaceutical industry through its proprietary platform that combines prefilled syringes with advanced injection devices. The company's technology is designed to improve the efficiency, safety, and scalability of drug delivery. It aims to meet the growing global demand for more reliable and accessible healthcare solutions, particularly in the field of injectable medications.
The equipment financing provided by Trinity Capital will be used to accelerate the build-out of ApiJect’s high-speed manufacturing capabilities in its facility located in Durham, North Carolina. This facility is part of ApiJect’s broader strategy to strengthen its manufacturing infrastructure and increase its production capacity to meet rising market demand. The funding will be allocated towards acquiring state-of-the-art equipment, enhancing production lines, and optimizing the facility to support the scalable production of ApiJect’s drug delivery devices.
